Hi Pixi, it looks like the patents cover combinations containing PBT2. Composition of matter may give them some coverage for other uses, but not sure.
[The United States Patent and Trademark Office (USPTO) has Granted a composition of matter patent for selected 8-hydroxyquinoline compounds, including its lead clinical asset, PBT2, in the United States. The patent titled '8-Hydroxyquinoline derivatives' also covers pharmaceutical compositions containing PBT2 and selected 8-hydroxyquinoline compounds.]
https://money.cnn.com/news/newsfeeds/articles/marketwire/0654817.htm
Ann: Notice of General Meeting/Proxy Form, page-71
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ATH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.3¢ |
Change
0.000(0.00%) |
Mkt cap ! $15.96M | |||
| Open | High | Low | Value | Volume |
| 0.4¢ | 0.4¢ | 0.3¢ | $8.021K | 2.111M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 40 | 23398919 | 0.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.4¢ | 132896552 | 36 |
View Market Depth
| Last trade - 16.10pm 11/10/2024 (20 minute delay) ? |
| ATH (ASX) Chart |